Results 101 to 104 of about 352 (104)
Some of the next articles are maybe not open access.

Long‐term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials

European Journal of Haematology, 2013
Francesco Rodeghiero   +1 more
exaly  

Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study

Lancet, The, 2016
Michael Tarantino   +2 more
exaly  

Romiplostim: A novel thrombopoiesis-stimulating agent

American Journal of Health-System Pharmacy, 2009
Sarah Perreault
exaly  

Evaluation of bleeding and thrombotic events during long‐term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)

Journal of Thrombosis and Haemostasis, 2010
exaly  
diseases of the blood and blood-forming organs
immune thrombocytopenia
thrombocytopenia
thrombopoietin
thrombopoietin receptor agonist
chemotherapy-induced thrombocytopenia
eltrombopag
aplastic anemia
thrombopoietin receptor agonists
previous   9  10  11  

Home - About - Disclaimer - Privacy